Publicaciones (26) Publicaciones de JOSE MANUEL TORRES IBAÑEZ

2023

  1. Rapid degeneration of iPSC-derived motor neurons lacking Gdap1 engages a mitochondrial-sustained innate immune response

    Cell Death Discovery, Vol. 9, Núm. 1

2021

  1. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment

    Neurotherapeutics, Vol. 18, Núm. 4, pp. 2565-2578

  2. c-MYC Triggers Lipid Remodelling During Early Somatic Cell Reprogramming to Pluripotency

    Stem Cell Reviews and Reports, Vol. 17, Núm. 6, pp. 2245-2261

2020

  1. Enhanced activity of glycolytic enzymes in Drosophila and human cell models of Parkinson's disease based on DJ-1 deficiency

    Free Radical Biology and Medicine, Vol. 158, pp. 137-148

  2. Mitochondrial dynamics and metabolism in induced pluripotency

    Experimental Gerontology, Vol. 133

2018

  1. MYC Induces a Hybrid Energetics Program Early in Cell Reprogramming

    Stem Cell Reports, Vol. 11, Núm. 6, pp. 1479-1492

2017

  1. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene

    Stem Cell Research, Vol. 18, pp. 1-4

  2. Mitochondrial Dynamics: In Cell Reprogramming as It Is in Cancer

    Stem Cells International, Vol. 2017

2016

  1. Dysfunctional mitochondrial fission impairs cell reprogramming

    Cell Cycle, Vol. 15, Núm. 23, pp. 3240-3250

  2. Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming

    Nature Communications, Vol. 7

  3. Silencing of hepatic fate-conversion factors induce tumorigenesis in reprogrammed hepatic progenitor-like cells

    Stem Cell Research and Therapy, Vol. 7, Núm. 1

2013

  1. Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression

    Cell Stem Cell, Vol. 12, Núm. 1, pp. 88-100

  2. Gata4 blocks somatic cell reprogramming by directly repressing Nanog

    Stem Cells, Vol. 31, Núm. 1, pp. 71-82

2012

  1. Efficient differentiation of Embryonic stem cells into mesodermal precursors by BMP, Retinoic Acid and Notch signalling

    PLoS ONE, Vol. 7, Núm. 4

2008

  1. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFκB and cooperating with Stat3

    Nature Cell Biology, Vol. 10, Núm. 2, pp. 194-201

2006

  1. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs

    Molecular Biology of the Cell, Vol. 17, Núm. 9, pp. 4002-4013

2005

  1. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases

    Journal of Biological Chemistry, Vol. 280, Núm. 32, pp. 28936-28943

  2. Functional definition of relevant epitopes on the tumor suppressor PTEN protein

    Cancer Letters, Vol. 223, Núm. 2, pp. 303-312

2004

  1. Regulation of MAPK cascades by protein tyrosine phosphatases.

    Methods in molecular biology (Clifton, N.J.), Vol. 250, pp. 103-112

2003

  1. A Novel Loss-of-Function Mutation (N48K) in the PTEN Gene in a Spanish Patient with Cowden Disease

    Journal of Investigative Dermatology, Vol. 121, Núm. 6, pp. 1356-1359